351 related articles for article (PubMed ID: 33432485)
1. Advances in Liver Cancer Stem Cell Isolation and their Characterization.
Liu L; Borlak J
Stem Cell Rev Rep; 2021 Aug; 17(4):1215-1238. PubMed ID: 33432485
[TBL] [Abstract][Full Text] [Related]
2. The power and the promise of liver cancer stem cell markers.
Liu LL; Fu D; Ma Y; Shen XZ
Stem Cells Dev; 2011 Dec; 20(12):2023-30. PubMed ID: 21651381
[TBL] [Abstract][Full Text] [Related]
3. Research progress and prospects of markers for liver cancer stem cells.
Zhu CP; Wang AQ; Zhang HH; Wan XS; Yang XB; Chen SG; Zhao HT
World J Gastroenterol; 2015 Nov; 21(42):12190-6. PubMed ID: 26576103
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of using cancer stem cell markers in isolating and characterizing liver cancer stem cells.
Wilson GS; Hu Z; Duan W; Tian A; Wang XM; McLeod D; Lam V; George J; Qiao L
Stem Cells Dev; 2013 Oct; 22(19):2655-64. PubMed ID: 23638793
[TBL] [Abstract][Full Text] [Related]
5. 8-bromo-7-methoxychrysin inhibits properties of liver cancer stem cells via downregulation of β-catenin.
Quan MF; Xiao LH; Liu ZH; Guo H; Ren KQ; Liu F; Cao JG; Deng XY
World J Gastroenterol; 2013; 19(43):7680-95. PubMed ID: 24431896
[TBL] [Abstract][Full Text] [Related]
6. Cancer Stem Cell Functions in Hepatocellular Carcinoma and Comprehensive Therapeutic Strategies.
Liu YC; Yeh CT; Lin KH
Cells; 2020 May; 9(6):. PubMed ID: 32466488
[TBL] [Abstract][Full Text] [Related]
7. The effects and mechanisms of SLC34A2 on tumorigenicity in human non-small cell lung cancer stem cells.
Jiang Z; Hao Y; Ding X; Zhang Z; Liu P; Wei X; Xi J
Tumour Biol; 2016 Aug; 37(8):10383-92. PubMed ID: 26846105
[TBL] [Abstract][Full Text] [Related]
8. A Novel Function for KLF4 in Modulating the De-differentiation of EpCAM
Karagonlar ZF; Akbari S; Karabicici M; Sahin E; Avci ST; Ersoy N; Ates KE; Balli T; Karacicek B; Kaplan KN; Celiker C; Atabey N; Erdal E
Cells; 2020 May; 9(5):. PubMed ID: 32408542
[TBL] [Abstract][Full Text] [Related]
9. Side population cell fractions from hepatocellular carcinoma cell lines increased with tumor dedifferentiation, but lack characteristic features of cancer stem cells.
Nakayama M; Ogasawara S; Akiba J; Ueda K; Koura K; Todoroki K; Kinoshita H; Yano H
J Gastroenterol Hepatol; 2014 May; 29(5):1092-101. PubMed ID: 24325739
[TBL] [Abstract][Full Text] [Related]
10. Detection of ALDH1 activity in rabbit hepatic VX2 tumors and isolation of ALDH1 positive cancer stem cells.
Gehlot P; Shukla V; Gupta S; Makidon PE
J Transl Med; 2016 Feb; 14():49. PubMed ID: 26873175
[TBL] [Abstract][Full Text] [Related]
11. CD34(+) Liver Cancer Stem Cells Were Formed by Fusion of Hepatobiliary Stem/Progenitor Cells with Hematopoietic Precursor-Derived Myeloid Intermediates.
Zeng C; Zhang Y; Park SC; Eun JR; Nguyen NT; Tschudy-Seney B; Jung YJ; Theise ND; Zern MA; Duan Y
Stem Cells Dev; 2015 Nov; 24(21):2467-78. PubMed ID: 26192559
[TBL] [Abstract][Full Text] [Related]
12. Dysregulation of signaling pathways and putative biomarkers in liver cancer stem cells (Review).
Song K; Wu J; Jiang C
Oncol Rep; 2013 Jan; 29(1):3-12. PubMed ID: 23076400
[TBL] [Abstract][Full Text] [Related]
13. Targeting PI3K/Akt/mTOR Pathway Identifies Differential Expression and Functional Role of IL8 in Liver Cancer Stem Cell Enrichment.
Kahraman DC; Kahraman T; Cetin-Atalay R
Mol Cancer Ther; 2019 Nov; 18(11):2146-2157. PubMed ID: 31439713
[TBL] [Abstract][Full Text] [Related]
14. Effective elimination of liver cancer stem-like cells by CD90 antibody targeted thermosensitive magnetoliposomes.
Yang R; An LY; Miao QF; Li FM; Han Y; Wang HX; Liu DP; Chen R; Tang SQ
Oncotarget; 2016 Jun; 7(24):35894-35916. PubMed ID: 27145285
[TBL] [Abstract][Full Text] [Related]
15. Novel therapeutic strategies for targeting liver cancer stem cells.
Oishi N; Wang XW
Int J Biol Sci; 2011 Apr; 7(5):517-35. PubMed ID: 21552419
[TBL] [Abstract][Full Text] [Related]
16. Genetic heterogeneity of liver cancer stem cells.
Kim M; Jo KW; Kim H; Han ME; Oh SO
Anat Cell Biol; 2023 Mar; 56(1):94-108. PubMed ID: 36384888
[TBL] [Abstract][Full Text] [Related]
17. [Molecular markers and mechanisms for stemness maintenance of liver cancer stem cells: a review].
Zhang N; Bai S; Zhang F; Shi M; Wang L; Wang L; Xu L; Yang Z; Yu C
Sheng Wu Gong Cheng Xue Bao; 2021 Aug; 37(8):2719-2736. PubMed ID: 34472291
[TBL] [Abstract][Full Text] [Related]
18. Strategies for isolating and enriching cancer stem cells: well begun is half done.
Duan JJ; Qiu W; Xu SL; Wang B; Ye XZ; Ping YF; Zhang X; Bian XW; Yu SC
Stem Cells Dev; 2013 Aug; 22(16):2221-39. PubMed ID: 23540661
[TBL] [Abstract][Full Text] [Related]
19. Notch and Wnt/β-catenin signaling pathway play important roles in activating liver cancer stem cells.
Wang R; Sun Q; Wang P; Liu M; Xiong S; Luo J; Huang H; Du Q; Geller DA; Cheng B
Oncotarget; 2016 Feb; 7(5):5754-68. PubMed ID: 26735577
[TBL] [Abstract][Full Text] [Related]
20. Identification of a unique hepatocellular carcinoma line, Li-7, with CD13(+) cancer stem cells hierarchy and population change upon its differentiation during culture and effects of sorafenib.
Yamada T; Abei M; Danjoh I; Shirota R; Yamashita T; Hyodo I; Nakamura Y
BMC Cancer; 2015 Apr; 15():260. PubMed ID: 25885470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
